2026-01-13 - Analysis Report
**English Report**
===============

**Stock Overview**
---------------

* Company Name: Tesla Inc
* Ticker: TSLA

**Cumulative Return Comparison**
-------------------------------

* Review stock (TSLA): **1060.18%**
* Comparison stock (VOO): **94.34%**
* Divergence: **955.90**
* Relative Divergence: **66.50%**

**Alpha, Beta Analysis**
----------------------

| Year | CAGR | MDD | Alpha | Beta | Cap(B) |
|------|------|-----|-------|------|-------|
| 2016-2018 | 9.0% | 30.5% | 5.0% | 1.3 | 73.8B |
| 2017-2019 | 13.0% | 40.0% | -4.0% | 1.3 | 92.8B |
| 2018-2020 | 588.0% | 40.0% | 568.0% | 1.3 | 782.3B |
| 2019-2021 | 759.0% | 29.9% | 715.0% | 1.3 | 1171.5B |
| 2020-2022 | 258.0% | 46.9% | 259.0% | 1.5 | 409.7B |
| 2021-2023 | 201.0% | 46.9% | 200.0% | 1.9 | 826.4B |
| 2022-2024 | 573.0% | 46.4% | 554.0% | 2.0 | 1343.1B |
| 2023-2025 | 512.0% | 57.1% | 450.0% | 2.3 | 1495.7B |

### Analysis

* Cumulative return shows a significant divergence between the review stock and the comparison stock.
* Alpha values indicate a consistent growth in review stock's return rates.

**Stock Price Fluctuations**
-----------------------------

* Close price: **$448.96**
* 5-day SMA: **$438.00**
* 20-day SMA: **$461.72**
* 60-day SMA: **$444.17**
* Recent fluctuation: **Sharp rebound** ( **0.89%** increase)

### Analysis

* Current stock price is above the 5-day and 60-day SMAs, indicating a short-term uptrend.
* The stock price has shown a sharp rebound in the recent fluctuation.

**RSI, PPO, and Delta_Previous_Relative_Divergence Analysis**
----------------------------------------------------------

| Metric | Value |
|--------|-------|
| MRI | 0.80 |
| RSI | 36.33 |
| PPO | -0.85 |
| Hybrid Signal | Buy (Cash 0%) |

| Metric | 20 days ago | 1 day ago |
|--------|-------------|-----------|
| Relative divergence change | - | 1.00 (+) |
| 7-day Rank change | 0 (0) | 0 (0) |
| 7-day Dynamic Expected Return change | -10.00 | -11.50 (-) |
| Expected Return (%) |  | **398.60%** |

### Analysis

* The MRI indicates a medium investment risk.
* The RSI and PPO values indicate a potential undervaluation.
* The hybrid signal recommends a buy with no cash allocation.
* The recent relative divergence change has improved, while the 7-day dynamic expected return change has worsened.

**Recent News & Significant Events**
-----------------------------------

* [2026-01-11] 5 Companies Racing to Dethrone Tesla—And the One Already Winning - 24/7 Wall St. (link)
* [2026-01-09] “The Math Doesn’t Add Up Anymore”: Tesla Stock (NASDAQ:TSLA) Gains, the Berlin Gigafactory at Risk? - TipRanks (link)
* [2026-01-11] Tesla: The Elon Premium Is Off The Charts (NASDAQ:TSLA) - Seeking Alpha (link)
* [2026-01-10] Why Evercore Expects Tesla (TSLA) Shares to Trade Sideways in the Near Term - Yahoo Finance (link)
* [2026-01-12] Tesla Inc. (TSLA) Wells Fargo Maintains Bearish Forecast - The Globe and Mail (link)
* [2026-01-10] YieldMax TSLA ETF Is Interesting, But Here's What I'd Buy Instead - Nasdaq (link)

### Analysis

* There are mixed reports on the company's performance and growth prospects.

**Analyst Opinions**
-------------------

```
Analyst Consensus:
- Key: Hold
- Mean (1=StrongBuy~5=Sell): 2.63 (~Hold)
- Opinions: 41
- Target Price (avg/high/low): 403.32 / 600.00 / 120.00
```

### Analysis

* Analysts are generally bearish on the stock, with a strong sell recommendation.

**Recent Earnings Analysis**
---------------------------

| Date | EPS | Revenue |
|-----|-----|---------|
| 2025-10-23 | 0.43 | 28.09 B$ |
| 2025-07-24 | 0.36 | 22.50 B$ |
| 2025-04-23 | 0.13 | 19.34 B$ |
| 2024-10-24 | 0.68 | 25.18 B$ |
| 2025-01-30 | 0.68 | 25.18 B$ |

### Analysis

* The company's EPS has been volatile, with a decrease in the previous quarter.
* Revenue has been steady, with a slight increase in the previous quarter.

**Revenue and Profitability**
-----------------------------

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $28.09B | 17.99% |
| 2025-06-30 | $22.50B | 17.24% |
| 2025-03-31 | $19.34B | 16.31% |
| 2024-12-31 | $25.71B | 16.26% |
| 2024-09-30 | $25.18B | 19.84% |

### Analysis

* Profit margin has been decreasing over the quarters.
* Revenue has been steady, with a slight increase in the previous quarter.

**Capital and Profitability**
-----------------------------

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $79.97B | 1.72% |
| 2025-06-30 | $77.31B | 1.52% |
| 2025-03-31 | $74.65B | 0.55% |
| 2024-12-31 | $72.91B | 3.17% |
| 2024-09-30 | $69.93B | 3.11% |

### Analysis

* Equity has been increasing over the quarters.
* ROE has been volatile, with a significant decrease in the previous quarter.

**Comprehensive Analysis**
---------------------------

* The review stock shows a significant cumulative return divergence.
* Alpha values indicate a consistent growth in review stock's return rates.
* The current stock price is above the 5-day and 60-day SMAs.
* The RSI and PPO values indicate a potential undervaluation.
* Analysts are generally bearish on the stock.
* The company's EPS has been volatile, with a decrease in the previous quarter.
* Revenue has been steady, with a slight increase in the previous quarter.
* Profit margin has been decreasing over the quarters.
* Equity has been increasing over the quarters.
* ROE has been volatile, with a significant decrease in the previous quarter.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.